Max Robotics — Global Service Robot Directory + US Certification

About

Oskar Bergengren is a leading urological researcher whose work focuses on patient-reported outcomes following surgical and radiotherapeutic treatments for prostate and bladder cancer. His major contributions center on leveraging large, population-based registries—most notably the National Prostate Cancer Register of Sweden—to provide real-world evidence on functional recovery and quality of life. In his landmark 2024 study (33 citations), Bergengren systematically assessed urinary, bowel, and erectile function alongside psychological well-being one year after radical prostatectomy or radiotherapy, filling a critical gap in contemporary, unselected cohorts. His 2022 investigation into surgeon volume and post-prostatectomy incontinence (13 citations) demonstrated that higher surgical volume is significantly associated with better continence outcomes, offering actionable insights for healthcare policy and surgical training. Additionally, his 2023 nationwide comparison of robot-assisted versus open cystectomy (9 citations) provided timely data on short-term outcomes for bladder cancer patients. Bergengren’s work is distinguished by its methodological rigor and direct relevance to clinical decision-making, making him a key voice in evidence-based urology.